Login/Sign Up

MRP ₹8276.4
(Inclusive of all Taxes)
₹1241.5 Cashback (15%)
Provide Delivery Location
About SORANIB 200MG TABLET
SORANIB 200MG TABLET belongs to the group of medicine called ‘anti-cancer’ that is primarily indicated in the treatment of kidney, liver, and thyroid cancer. Kidney cancer is also known as renal cancer is a disease in which healthy cells of the kidney become malignant (cancerous), grow in an uncontrolled manner, and forms a tumour. Cancer of the liver is known as liver cancer. When cancer occurs in the liver, it destroys healthy cells of the liver and affects the ability of the liver to function normally. Thyroid cancer occurs when cells start multiplying in the thyroid gland and form a tumour. The tumour is a collection of abnormal cells.
SORANIB 200MG TABLET contains 'Sorafenib' that falls in the category of medicines known as 'kinase inhibitors'. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells.
Take SORANIB 200MG TABLET as prescribed by your doctor. You are suggested to take SORANIB 200MG TABLET as long as your doctor has prescribed it after checking your medical condition. In some cases, you may experience certain common side-effects such as itching or skin rash, acne, dry skin, vomiting, diarrhoea, and loss of appetite. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.
To treat your condition effectually, continue taking SORANIB 200MG TABLET for as long as your doctor has prescribed. Do not take SORANIB 200MG TABLET if you are pregnant or planning for pregnancy as SORANIB 200MG TABLET causes serious birth defects. SORANIB 200MG TABLET should not be taken by breastfeeding mothers as it passes into breast milk and may cause a possible risk to the infant. Elderly people are more sensitive to the medicine so the doctor may adjust the dosage according to the condition. Avoid consuming alcohol along with SORANIB 200MG TABLET as it could lead to increased dizziness.
Uses of SORANIB 200MG TABLET
SORANIB 200MG TABLET is used in the treatment of kidney, liver, and thyroid cancer. The detailed uses of SORANIB 200MG TABLET are as follows:

Have a query?
Directions for Use
Medicinal Benefits
SORANIB 200MG TABLET is a ' tyrosine kinase inhibitor (TKI)', that stops the uncontrolled growth and spread of cancerous cells. SORANIB 200MG TABLET is effective in treating thyroid, liver and kidney cancer. It acts by stopping the action of the abnormal protein that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed it undergoes a usual process of maturity. Cancerous cells form new cells more quickly so SORANIB 200MG TABLET targets cancerous cells and block the action of Tyrosine kinases enzymes (responsible for causing cancer). In this way, SORANIB 200MG TABLET stops the production, spread and growth of cancerous cells in the body.
How SORANIB 200MG TABLET Works
Storage
What if I have taken an overdose of SORANIB 200MG TABLET
Drug Warnings
SORANIB 200MG TABLET may make you more susceptible to infections; consult your doctor if you develop any signs of infections such as fever, sore throat, breathlessness, jaundice, unexplained bleeding, or bruising. Your doctor may advise you to undergo regular blood tests, kidney and liver tests to monitor your condition. Inform your doctor about your health condition and medicines to rule out any unpleasant side-effects. Before your doctor prescribes you SORANIB 200MG TABLET , tell them if you have heart problems, high blood pressure, bleeding issues, surgery, or an electrolyte imbalance (like abnormal levels of magnesium, calcium, or potassium in the blood). SORANIB 200MG TABLET is restricted to use in persons who are sensitive to any of its constituent or have squamous cell lung cancer or already taking carboplatin and paclitaxel.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
RXSamarth Life Sciences Pvt Ltd
₹78
(₹2.6 per unit)
RXRPG Life Sciences Ltd
₹1250
(₹9.38 per unit)
RXIntas Pharmaceuticals Ltd
₹5995
(₹40.97 per unit)
Alcohol
Unsafe
You are recommended to avoid alcohol consumption with SORANIB 200MG TABLET as it may increase the risk of side effects such as dizziness, drowsiness, or difficulty in concentrating.
Pregnancy
Unsafe
SORANIB 200MG TABLET is restricted to use in pregnancy. A woman needs to have a negative pregnancy test before starting treatment with this medicine. It is better to use effective birth control methods to prevent pregnancy while taking this medicine or for at least 6 months after taking the last dose of SORANIB 200MG TABLET .
Breast Feeding
Unsafe
SORANIB 200MG TABLET should not be taken by breastfeeding mothers as it passes into breast milk and may cause a possible risk to the infant.
Driving
Caution
It is not known if SORANIB 200MG TABLET may affect your driving ability or not.
Liver
Safe if prescribed
SORANIB 200MG TABLET is safe to take by patients dealing with liver cancer as prescribed by their doctor. The dose may be adjusted by the doctor according to the medical condition of the patient.
Kidney
Safe if prescribed
SORANIB 200MG TABLET is safe to take by patients dealing with kidney cancer as prescribed by their doctor. The dose may be adjusted by the doctor according to the medical condition of the patient.
Children
Caution
SORANIB 200MG TABLET is not recommended for children below 18 years as the safety and effectiveness were not established.
SORANIB 200MG TABLET is used in the treatment of kidney, liver, and thyroid cancer.
SORANIB 200MG TABLET is safe to be taken by a diabetic person. However, take SORANIB 200MG TABLET only after asking with a doctor as they may adjust the dosing according to the condition of the patient.
SORANIB 200MG TABLET is restricted to use in pregnancy. A woman needs to have a negative pregnancy test before starting treatment with this medicine. It is better to use effective birth control methods to prevent pregnancy while taking this medicine or for at least 6 months after taking the last dose of SORANIB 200MG TABLET .
SORANIB 200MG TABLET should be stopped in cases where a person faces a serious side effect that affects the quality of life. Otherwise, you need to keep taking SORANIB 200MG TABLET until your doctor asks you to stop it.
Liver cancer may spread fast depending upon the type of cancer. Hemangiosarcoma and angiosarcoma (the type of liver cancer) spread quickly while hepatocellular carcinoma spreads slowly in the disease.
Before your doctor prescribes you SORANIB 200MG TABLET , tell them if you have heart problems, high blood pressure, bleeding issues, surgery, or an electrolyte imbalance (like abnormal levels of magnesium, calcium, or potassium in the blood).
SORANIB 200MG TABLET is restricted to use in persons who are sensitive to any of its constituents or have squamous cell lung cancer or already taking carboplatin and paclitaxel.
If you are going for surgery tell your dentist ahead that you are taking this medicine. You need to stop taking it at least 10 days after having surgery.
SORANIB 200MG TABLET should be taken as advised by the doctor. It is usually taken without food at least 1 hour before or 2 hours after food. Swallow it as a whole with water. Do not crush, break or chew it.
You are advised to take SORANIB 200MG TABLET for as long as it is prescribed by your doctor based on your medical condition. Do not stop taking SORANIB 200MG TABLET even if you feel better till the treatment is completed as the symptoms may reoccur.
No, taking treatment along with SORANIB 200MG TABLET is not recommended. It is used alone rather than in combination with other treatments to avoid the unwanted side-effects. However, consult the doctor before the treatment.
You will know if SORANIB 200MG TABLET is working if you notice the changes in the symptoms, decrease in the tumour size, or if the blood test shows positive changes. Your doctor will regularly check to know the condition.
The severe side-effects associated with SORANIB 200MG TABLET include heart attack, heart failure, increased risk of bleeding, liver problem, allergic reactions, gastro-intestinal perforations (a tear in wall of stomach or intestine).
Yes, SORANIB 200MG TABLET may decrease the blood sugar levels, which may sometimes lead to fainting. Diabetic patients should check their blood sugar regularly. Consult the doctor if this condition worsens.
No, this isn’t dangerous.Hand-foot reactions (refers to palms and soles) are the most common adverse reactions of SORANIB 200MG TABLET . You should consult the doctor if this condition persists for longer durations or worsens.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Celon Laboratories Pvt Ltd
Natco Pharma Ltd
Cipla Ltd
Adley Formulations
BDR Pharmaceuticals Internationals Pvt Ltd
Sun Pharmaceutical Industries Ltd
Admac Lifesciences(Oncology)
Halsted Pharma Pvt Ltd
Glenmark Pharmaceuticals Ltd
Neon Laboratories Ltd
United Biotech Pvt Ltd
Alkem Laboratories Ltd
Samarth Life Sciences Pvt Ltd
Zydus Cadila
Zydus Healthcare Ltd
Emcure Pharmaceuticals Ltd
Axiommax Oncology Pvt Ltd
GLS Pharma Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
Hetero Healthcare Pvt Ltd
Fresenius Kabi India Pvt Ltd
Pfizer Ltd
Torrent Pharmaceuticals Ltd
Cadila Healthcare Ltd
Getwell Life Sciences India Pvt Ltd
Therdose Pharma Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Novartis India Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Aureate Healthcare
Biochem Pharmaceutical Industries Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Delarc Pharmaceuticals Pvt Ltd
Zee Laboratories Ltd
Amps Biotech Biotech Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Aimcad Biotech Pvt Ltd
Getwell Oncology Pvt Ltd
Msn Laboratories Pvt Ltd
Reliance Formulation Pvt Ltd
Allieva Pharma Pvt Ltd
Astra Zeneca Pharma India Ltd
Lucien Life Sciences
Getwell Pharmaceutical Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Bhardwaj India Pvt Ltd
Caitlin Oncology
Del Trade International Pvt Ltd
Medaegis Biotek Pvt Ltd
Panacea Biotec Ltd
Cadila Pharmaceuticals Ltd
Dabur India Ltd
Oncostar Pharma Pvt Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cytogen
Symbion Lifescience
Vhb Life Sciences Inc
Zuvius Lifesciences Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Miracalus Pharma Pvt Ltd
Bruck Pharma Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Adley Oncology
Admac Pharma Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Reliance Life Sciences Pvt Ltd
Sayre Therapeutics Pvt Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Zuventus Healthcare Ltd
Astellas Pharma India Pvt Ltd
Boehringer Ingelheim India Pvt Ltd
Mankind Pharma Pvt Ltd
Roche Diagnostics India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley & Bdl
Aprazer Healthcare Pvt Ltd
Aureate Pharma
Caitlin Life Care
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd